VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...
The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback